2018 Speakers

Previous Conference Gallery

Paradigm Global Events

ADD THIS EVENT TO YOUR CALENDAR

24 - 26 Sep 2018

Windows   Apple   Google

Who Attends

Orphan Drugs & Rare Diseases congress provides a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, orphan drugs developers as well as regional and local manufacturers.

 

AbbVie – Access Matters – Actelion – Agility Clinical Inc – Albireo Pharma – Alexion Pharma GmbH – Alexion Pharmaceuticals, Inc. – Alnylam – Amicus Therapeutics – Armetheon Inc – Barrington James – Bay City Capital – BenevolentAI – Biogen – Biogen Idec Japan – Biomedical Systems – BioPontis Alliance for Rare Diseases – BluePrint Orphan – Stratis Group – Boehringer Ingelheim – Bridge Consulting – BridgeBio – Cambridge Rare Diseases Network – Celgene – CentogeneheckOrphan – Chiesi Farmaceutici S.p.A – Clincierge – Codenix – Complete HealthVizion – Cote Orphan – Covance Laboratories – CRF Health – Cymabay Therapeutics – Cytel – DefiniGEN Ltd – DNAlight Therapeutics – Dolon Ltd – Dravet Syndrome – Foundation Europe – Drug Committee of the German Medical Association (AKDÄ) – Eiger BioPharmaceuticals – EMD Serono, Inc – Enable Biosciences Inc – Evotec (UK) – F. Hoffmann – La Roche Ltd – Facio Therapies – GB Pharma Services & Consulting Srl – Genentech / Codon Capital – Genetic – Global Service Pharmaceuticals SAS – GlobalData – Glycomine Inc. – GMAx Consulting LLC – GSK – Guthy Jackson Foundation – GW Pharmaceuticals – Houston Methodist Research Institute – HSGBU Oracle UK – INC Research/inVentiv Health – IndieBio – INSERM – Jain Foundation – LYSOGENE – Manson Associates – MAPI Group – MC Business Consulting – MEDExpansion – Medical Marketing Economics – Medicopharma Solutions – Medpace – Merck – Mereo BioPharma – Mission Bay Capital – Mitsubishi Tanabe Pharma Europe Ltd – Myokardia, Inc. – MytoDys Therapeutics – National Alliance of People with Rare Diseases – Novartis – NYSE – ONXEO – Opsona Therapeutics – Optum – Oracle – Orphan Drugs Industry Advisory & Intelligence – Palo Alto Investors – Pfizer – Premier Research – PSR Group B.V. – Pulse InfoFrame – Qiagen – Rare Disease Report – Rare Genomics Institute – Rarebase – Raremark – Recursion Pharmaceuticals – REGENXBIO – Rho Inc. – Roche – Root Lines Technology – Royal Holloway, University of London – S3 Connected Health – Sanofi Genzyme – Sanofi Pasteur MSD – Savara Pharmaceuticals – Seeker Health – Shire – Simbec Orion – Siolta Therapeutics – Stanford University – SyntheX, Inc – TB – SEQ Inc. – The Planning Shop International – The Scripps Translational Science Institute – UCSF Helen Diller Family Comprehensive Cancer Center – Venn Life Sciences – Vertex – Vifor Pharma – Xenon Pharmaceuticals Inc.

LOOKING FORWARD TO MEETING YOU IN BOSTON!

To Sponsor/Exhibit

To Speak

To Register

sponsor@paradigmglobalevents.com
Tel. +44 203 567 1321

jocelynr@paradigmglobalevents.com
Tel. +44 203 567 1321

booking@paradigmglobalevents.com
Tel. +44 203 567 1321